F17.2 supports nicotine dependence documentation, but clinicians choose the diagnosis
F17.2 is the ICD-10-CM code family for nicotine dependence. In behavioral health documentation, it may appear when nicotine use is clinically relevant to assessment, treatment planning, progress notes, care coordination, or co-occurring mental health concerns.
The code family includes more specific options for product type, remission status, withdrawal, and nicotine-induced conditions. For that reason, F17.2 is best understood as a documentation category rather than a complete clinical description by itself. The treating clinician is responsible for diagnosis selection, code specificity, and final documentation.
For therapists, counselors, social workers, psychologists, and psychiatric providers, the practical question is not just “Which code applies?” It is “Does the note clearly support the clinical picture, the intervention, and the treatment plan?”
Common F17.2 code options clinicians may see
Many EHRs and billing systems display F17.2 as a broader family with related subcodes. The most appropriate code depends on the clinician’s assessment, payer requirements, and the client’s documented presentation.
- F17.200 — Nicotine dependence, unspecified, uncomplicated
- F17.201 — Nicotine dependence, unspecified, in remission
- F17.203 — Nicotine dependence, unspecified, with withdrawal
- F17.210 — Nicotine dependence, cigarettes, uncomplicated
Additional related codes may specify cigarettes, chewing tobacco, other tobacco products, withdrawal, remission, or nicotine-induced disorders. If the record only states “uses nicotine” or “smokes sometimes,” that may not support a dependence diagnosis. Documentation should reflect the assessed symptoms and clinical rationale.
Clinical documentation should describe the nicotine use pattern
A useful note gives enough context for another treating provider to understand the client’s nicotine use and why it matters to care. This does not mean writing a long narrative in every session. It means capturing the details that support assessment and treatment decisions.
Relevant documentation may include:
- Type of nicotine product, such as cigarettes, vaping products, chewing tobacco, or other tobacco products
- Frequency, amount, duration, and recent changes in use
- Cravings, withdrawal symptoms, tolerance, unsuccessful quit attempts, or continued use despite consequences
- Relationship between nicotine use and anxiety, depression, sleep, irritability, trauma symptoms, concentration, or medical concerns
For example, “Client reports smoking one pack per day for 12 years” is more clinically useful than “client smokes.” A stronger assessment note might add: “Client reports morning cravings, irritability during prior quit attempts, and difficulty reducing use despite wanting to improve breathing and reduce anxiety-related smoking.”
F17.2 often appears alongside mental health treatment goals
Nicotine dependence may be the primary focus of care, but in many behavioral health settings it is documented as part of a broader clinical picture. A client may present for panic attacks, depression, trauma symptoms, mood instability, or stress related to work and family demands. Nicotine use may become clinically relevant when it affects symptoms, functioning, coping patterns, or medication planning.
Common therapy contexts include a client who smokes more during periods of anxiety, uses nicotine to regulate mood after conflict, struggles with withdrawal during a quit attempt, or feels shame after repeated unsuccessful efforts to stop. Some clients may not be ready to quit but are willing to track triggers or discuss harm-reduction steps. Others may request direct cessation support.
Good documentation connects nicotine-related concerns to treatment without overstating progress or assuming motivation. A note can state, “Client is ambivalent about quitting but agreed to monitor cravings and identify high-risk times,” rather than implying that cessation is already an active goal.
Progress notes should connect symptoms, interventions, and client response
For ongoing sessions, the note should show what changed since the last contact, what the clinician did, how the client responded, and what will happen next. This is especially helpful when nicotine dependence is addressed within therapy rather than through a stand-alone cessation program.
A SOAP-style note might include:
- Subjective: Client reported increased cravings after work and smoking more during arguments with partner.
- Objective: Client appeared restless and described irritability during previous quit attempts.
- Assessment: Nicotine use remains linked to stress response and avoidance-based coping.
- Plan: Practice urge-surfing, track triggers, review coping alternatives, and revisit readiness next session.
A DAP note could document the same session more briefly: “Client reported smoking 15 cigarettes daily, with strongest cravings after work. Clinician used motivational interviewing to explore ambivalence and CBT strategies to identify trigger-thought-behavior patterns. Client identified two high-risk situations and agreed to track cravings before next session.”
Treatment plans should define the role of nicotine-related work
If nicotine dependence is part of the treatment plan, goals and objectives should be specific enough to guide care. “Stop smoking” may be too broad on its own. A better plan explains the client’s stage of change, measurable objectives, and planned interventions.
Examples of treatment plan language include:
- Goal: Reduce nicotine-related impairment and increase use of non-nicotine coping skills during stress.
- Objective: Client will identify at least three common triggers for nicotine cravings within four sessions.
- Intervention: Clinician will use motivational interviewing to explore ambivalence and support client-directed change.
- Intervention: Clinician will teach CBT-based coping skills for cravings, irritability, and high-risk situations.
Some clients may also benefit from coordination with a primary care provider, prescriber, quitline, or tobacco cessation program. If referrals are discussed, document the client’s response, consent for coordination when applicable, and any follow-up steps.
Assessment notes should avoid vague or unsupported statements
Short notes can still be clinically clear. The key is to avoid statements that do not show the basis for the diagnosis or treatment focus. “Client has nicotine dependence” may be true, but it does not describe the assessed pattern. “Client is addicted to vaping” may sound informal and may not meet documentation standards in many clinical records.
Consider replacing vague wording with clinically observable details:
- Instead of “client smokes a lot,” write “client reports smoking approximately one pack per day, with first cigarette within 30 minutes of waking.”
- Instead of “client can’t quit,” write “client reports three quit attempts in the past year, each followed by relapse during work-related stress.”
- Instead of “client has withdrawal,” write “client reports irritability, restlessness, and strong cravings when reducing use.”
- Instead of “client is noncompliant,” write “client reports ambivalence about cessation and agreed to track use before setting a reduction goal.”
This type of wording keeps the note behavioral, measurable, and clinically grounded. It also reduces the risk of judgmental language in the record.
Co-occurring concerns may affect nicotine dependence documentation
Nicotine use can intersect with anxiety, depression, trauma, ADHD symptoms, substance use, sleep problems, and medical conditions. Documentation should clarify the relationship when it is clinically relevant. For example, a client may use nicotine to manage panic symptoms, stay awake during depressive episodes, reduce appetite, or cope with trauma reminders.
Clinicians should also document risk and safety considerations when they arise. Nicotine dependence alone does not imply acute risk, but the broader session may include suicidal ideation, substance use relapse risk, domestic conflict, medication concerns, or other issues that require standard clinical assessment.
If the client is taking psychiatric medication, prescriber coordination may be relevant, particularly when changes in nicotine use could affect the clinical picture. The behavioral health note does not need to become a medical note, but it should document referrals, coordination, and client consent according to the practice’s policies.
Example progress note for nicotine dependence work
The following example is for documentation structure only. It is not a recommendation to assign F17.2 or any related code. The clinician should select diagnoses based on their own assessment and applicable documentation requirements.
DAP progress note example:
Data: Client reported increased nicotine use over the past week, from approximately 10 cigarettes per day to 15 cigarettes per day, primarily after work and following conflict with partner. Client described cravings, irritability when delaying smoking, and frustration about prior quit attempts. No acute safety concerns reported during session.
Assessment: Nicotine use appears connected to stress regulation and conflict-related coping. Client remains ambivalent about setting a quit date but expressed interest in reducing automatic smoking after work. Progress is mixed, with increased awareness of triggers but continued difficulty using alternative coping skills during high-stress periods.
Plan: Continue motivational interviewing and CBT-based craving management. Client will track cravings, trigger situations, and coping attempts on at least four days before next session. Clinician will review readiness for reduction goal and discuss referral options if client requests additional cessation support.
How AutoNotes supports F17.2 documentation workflows
AutoNotes helps clinicians create structured, editable progress note drafts from session details. For nicotine dependence documentation, that can mean a clearer starting point for recording use patterns, triggers, withdrawal symptoms, interventions, client response, and plan updates.
AutoNotes does not assign diagnoses or replace clinical judgment. The clinician remains responsible for reviewing the draft, selecting the appropriate ICD-10-CM code, editing the language, and finalizing the record. This is especially important for F17.2 because code specificity may depend on product type, remission status, withdrawal, or other clinical details.
For busy therapists and behavioral health professionals, the benefit is practical: fewer blank-screen moments and more consistent note structure. AutoNotes can support SOAP notes, DAP notes, intake documentation, treatment planning, and other behavioral health workflows while keeping the provider in control of the final note.
Build clearer nicotine dependence notes with less after-hours writing
F17.2 documentation works best when the clinical record connects the client’s nicotine use pattern, symptoms, interventions, response, and next steps. The code alone does not tell that story. A clear note does.
If documentation is taking over evenings or creating inconsistent records across sessions, AutoNotes can help you draft structured notes faster while preserving clinician review and editing. Start your free trial and see how AI-assisted documentation can support your progress note workflow.
